Real-time enrollment status for this hemophilia b clinical trial
Current Status
Recruiting
Checked: August 31, 2026 at 8:50 AM UTC
| NCT Number | NCT07080905 |
| Recruiting Status | Recruiting |
| Condition | Hemophilia B |
| Phase | PHASE3 |
| Target Enrollment | 20 participants |
| Active Locations | 5 sites in the US |
| Sponsor | CSL Behring |
| Last Updated on CT.gov | August 5, 2026 (3 weeks ago) |
As of August 31, 2026: Clinical trial NCT07080905 is currently recruiting participants. This phase3 study for hemophilia b is actively seeking new participants at 5 locations across the United States. The study is sponsored by CSL Behring. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07080905 is actively recruiting participants as of August 31, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 5 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07080905 was last updated 3 weeks ago (August 5, 2026). HelloStudys verifies this status automatically.